Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Survival outcomes in patients having IPF (N = 30)

From: Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy

Characteristics X-ray (n = 22) Proton (n = 8) p value
All patients
 Treatment-related death 4/22 (18.2%) 0/8 (0%) 0.140
 6 months OS 67.9% 100% 0.081
 1 year OS 46.4% 66.7%  
GAP stage I n = 9 n = 1  
 6 months OS 88.9% 100% 0.501
 1 year OS 76.2% 100%  
GAP stage II-III n = 13 n = 7 0.036
 6 months OS 52.7% 100%  
 1 year OS 26.4% 50.0%  
  1. IPF idiopathic pulmonary fibrosis, OS overall survival